Equities

10X Capital Venture Acquisition Corp III

10X Capital Venture Acquisition Corp III

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)10.90
  • Today's Change-0.07 / -0.64%
  • Shares traded4.32k
  • 1 Year change+5.31%
  • Beta--
Data delayed at least 15 minutes, as of May 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

10X Capital Venture Acquisition Corp. III is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. It may pursue an initial business combination target in any business or industry. The Company intends to focus on identifying high growth technology and tech-enabled businesses domestically and abroad in the consumer Internet, ecommerce, software, healthcare, transportation/mobility, and financial services industries, as well as other industries that are being disrupted by advances in technology and in technology paradigms, including artificial intelligence (AI), automation, data science, ecommerce, and Software-as-a-Service (SaaS). It has no operations and has no revenues.

  • Revenue in USD (TTM)0.00
  • Net income in USD-1.25m
  • Incorporated2021
  • Employees--
  • Location
    10X Capital Venture Acquisition Corp III1 World Trade Center, Floor 85NEW YORK 10007United StatesUSA
  • Phone+1 (212) 257-0069
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
VCXB:ASQ since
announced
Transaction
value
American Gene Technologies IncAnnounced09 Aug 202309 Aug 2023Announced3.51%800.00m
Data delayed at least 15 minutes, as of May 08 2024.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Voya Global Advantage and Prem Oppty Fd-100.00bn-100.00bn137.61m--------------------------------------------------------------
Twelve Seas Investment Co II0.003.55m139.34m--104.794.52----0.10230.10230.002.370.00------1.86--1.88--------------0.0252------373.14------
Ellington Credit Co42.55m4.56m139.93m170.0028.050.964--3.290.25170.25172.867.320.0426--1.01250,288.200.4560.15683.521.36-14.9928.3110.715.88----0.8426689.7821.55-4.85115.10-----9.88
Israel Acquisitions Corp0.006.07m140.05m--34.771.4632.20--0.31430.31430.007.470.00------7.83--8.16--------------0.00------8,542.42------
Special Opportunities Fund Inc-100.00bn-100.00bn140.45m--------------------------------------------------------------
Brandywineglbl Global Incm Opp Fund Inc21.37m7.36m140.72m--19.120.9996--6.580.43820.43821.278.380.0816--4.61--2.811.263.711.6071.1374.4434.4320.82--2.180.4411350.2111.09-4.21113.95----1.14
Bny Mellon Municipal Income Inc9.57m2.12m141.25m2.60k66.520.9972--14.760.10230.10230.4618.280.042--2.52--1.49-0.17741.51-0.178267.0075.2735.52-4.40--2.410.00---4.61-6.79105.09-----13.66
10X Capital Venture Acquisition Corp III0.00-1.25m143.82m----6.85-----0.0842-0.08420.001.590.00-------0.7143---0.7265--------------0.00------1,665.32------
Morgan Stanley Emerging Mkt Debt FundInc-100.00bn-100.00bn144.29m--------------------------------------------------------------
Linike Medical Group Ltd0.00-306.90k147.17m-----------0.1102-0.11020.00-0.1530.00-------278.62---------------------------651.26------
Western Asset Municipal Hgh Incm Fnd Inc-100.00bn-100.00bn147.66m--------------------------------------------------------------
New Germany Fund Inc.-100.00bn-100.00bn148.37m--------------------------------------------------------------
Blockchain Coinvestors Acqustn Corp I0.006.08m149.12m0.0024.7916.1524.52--0.44770.44770.000.68710.00------3.59--3.71--------------0.1793-------34.96------
Destiny Tech100 Inc360.46k-4.14m149.82m----2.85--415.63-0.3806-0.38060.03314.840.0063--1.91---7.18---7.33---460.77---1,148.67-----1.930.00--95.64---5.41------
Data as of May 08 2024. Currency figures normalised to 10X Capital Venture Acquisition Corp III's reporting currency: US Dollar USD

Institutional shareholders

15.45%Per cent of shares held by top holders
HolderShares% Held
SkyView Investment Advisors LLCas of 31 Dec 2023400.00k3.03%
HGC Investment Management, Inc.as of 31 Dec 2023400.00k3.03%
Koch Industries, Inc. (Investment Management)as of 31 Dec 2023400.00k3.03%
Polar Asset Management Partners, Inc.as of 31 Dec 2023400.00k3.03%
Mizuho Securities USA LLCas of 31 Dec 2023187.50k1.42%
Walleye Capital LLCas of 31 Dec 2023112.50k0.85%
Sandia Investment Management LPas of 31 Dec 2023100.00k0.76%
JPMorgan Alternative Asset Management, Inc.as of 31 Dec 202223.85k0.18%
Cowen & Co. LLCas of 31 Mar 202414.11k0.11%
Accelerate Financial Technologies, Inc.as of 29 Feb 2024100.000.00%
More ▼
Data from 31 Dec 2022 - 31 Mar 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.